Dr Jennifer Mcnulty, MD | |
801 S Washington St, Naperville, IL 60540-7430 | |
(630) 527-3355 | |
(630) 527-5018 |
Full Name | Dr Jennifer Mcnulty |
---|---|
Gender | Female |
Speciality | Emergency Medicine - Pediatric Emergency Medicine |
Location | 801 S Washington St, Naperville, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316099070 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207PP0204X | Emergency Medicine - Pediatric Emergency Medicine | (Illinois) | Primary |
Entity Name | Edward Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013969013 PECOS PAC ID: 0042108110 Enrollment ID: O20040309001279 |
News Archive
Oregon Health & Science University Doernbecher Children's Hospital will lead the next phase of a landmark clinical trial to further assess the safety and preliminary effectiveness of purified human neural stem cells (HuCNS-SC-) as a potential treatment for infantile or late-infantile neuronal ceroid lipofuscinosis (NCL), a rare and currently fatal neurodegenerative disorder that affects infants and children.
AngioDynamics today announced the first patient treatment and growing enrollment in a pilot study of the use of the Company's NanoKnifeĀ® Irreversible Electroporation (IRE) System in the treatment of early stage hepatocellular carcinoma (HCC), or primary liver cancer. This clinical trial is being conducted under the supervision of Professor Jordi Bruix of the Barcelona Clinic Liver Cancer Group of the University of Barcelona and Professor Riccardo Lencioni of the University of Pisa School of Medicine.
The phase I clinical study will enroll 20 patients with advanced solid cancers (including most common tumor types), and is the culmination of more than a decade of work by a team of researchers led by Professor Esther H. Chang, Ph.D. at the Lombardi Comprehensive Cancer Center.
Salix Pharmaceuticals, Ltd. today announced that it intends to offer, subject to market and other conditions, $200 million aggregate principal amount of its convertible senior notes due 2015 under an automatically effective shelf registration statement on file with the Securities and Exchange Commission. Salix also expects to grant the underwriters an overallotment option to purchase up to an additional $30 million aggregate principal amount of notes on the same terms and conditions.
Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced a definitive agreement to acquire Oridion Systems Ltd.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jennifer Mcnulty, MD 715 Hillside Ave, Glen Ellyn, IL 60137-4616 Ph: (630) 545-1076 | Dr Jennifer Mcnulty, MD 801 S Washington St, Naperville, IL 60540-7430 Ph: (630) 527-3355 |
News Archive
Oregon Health & Science University Doernbecher Children's Hospital will lead the next phase of a landmark clinical trial to further assess the safety and preliminary effectiveness of purified human neural stem cells (HuCNS-SC-) as a potential treatment for infantile or late-infantile neuronal ceroid lipofuscinosis (NCL), a rare and currently fatal neurodegenerative disorder that affects infants and children.
AngioDynamics today announced the first patient treatment and growing enrollment in a pilot study of the use of the Company's NanoKnifeĀ® Irreversible Electroporation (IRE) System in the treatment of early stage hepatocellular carcinoma (HCC), or primary liver cancer. This clinical trial is being conducted under the supervision of Professor Jordi Bruix of the Barcelona Clinic Liver Cancer Group of the University of Barcelona and Professor Riccardo Lencioni of the University of Pisa School of Medicine.
The phase I clinical study will enroll 20 patients with advanced solid cancers (including most common tumor types), and is the culmination of more than a decade of work by a team of researchers led by Professor Esther H. Chang, Ph.D. at the Lombardi Comprehensive Cancer Center.
Salix Pharmaceuticals, Ltd. today announced that it intends to offer, subject to market and other conditions, $200 million aggregate principal amount of its convertible senior notes due 2015 under an automatically effective shelf registration statement on file with the Securities and Exchange Commission. Salix also expects to grant the underwriters an overallotment option to purchase up to an additional $30 million aggregate principal amount of notes on the same terms and conditions.
Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced a definitive agreement to acquire Oridion Systems Ltd.
› Verified 8 days ago
Mohamed I Jabri, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1149 Dickens Ave, Naperville, IL 60563 Phone: 630-548-1407 | |
Dr. Sangita X Rangala, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington St, Naperville, IL 60540 Phone: 630-527-3288 Fax: 630-527-5018 | |
Jordan B Moskoff, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4003 S Route 59, Naperville, IL 60564 Phone: 888-693-6437 Fax: 815-730-6368 | |
Dr. Thomas H Oh, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington St, Naperville, IL 60540 Phone: 630-527-3000 | |
Dr. Alan S. Kaplan, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 801 S Washington St, Naperville, IL 60540 Phone: 630-527-3000 | |
Dr. Karen M Balzanto, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 801 S Washington St, Naperville, IL 60540 Phone: 630-527-3355 Fax: 630-527-5018 | |
Dr. Edward Parker, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington St, Naperville, IL 60540 Phone: 630-527-3000 |